Gene · 186
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inverse Salt Sensitivity of Blood Pressure Is Associated with an Increased Renin-Angiotensin System Activity. | Biomedicines | 2022 | 36359330 | PubTator, text mining | PubMed |
| The new mechanism of cognitive decline induced by hypertension: High homocysteine-mediated aberrant DNA methylation. | Front Cardiovasc Med | 2022 | 36352848 | PubTator, text mining | PubMed |
| Effects of forest environment (Shinrin-yoku/Forest bathing) on health promotion and disease prevention -the Establishment of "Forest Medicine". | Environ Health Prev Med | 2022 | 36328581 | PubTator, text mining | PubMed |
| Losartan as an ACE inhibitor: a description of the mechanism of action through quantum biochemistry. | RSC Adv | 2022 | 36320533 | PubTator, text mining | PubMed |
| Identification of TIMP2 as a Prognostic Biomarker and Its Correlation with Tumor Immune Microenvironment: A Comprehensive Pan-Cancer Analysis. | J Oncol | 2022 | 36304987 | PubTator, text mining | PubMed |
| Construction of an immune-related signature for predicting the ischemic events in patients undergoing carotid endarterectomy. | Front Genet | 2022 | 36299596 | PubTator, text mining | PubMed |
| GPCRs in Intracellular Compartments: New Targets for Drug Discovery. | Biomolecules | 2022 | 36291552 | PubTator, text mining | PubMed |
| Ischemic Stroke, Lessons from the Past towards Effective Preclinical Models. | Biomedicines | 2022 | 36289822 | PubTator, text mining | PubMed |
| Protecting glomerulus: role of angiotensin-II type 2 receptor. | Clin Sci (Lond) | 2022 | 36287192 | PubTator, text mining | PubMed |
| Mechanism of an intramembrane chaperone for multipass membrane proteins. | Nature | 2022 | 36261528 | PubTator, text mining | PubMed |
| Substrate-driven assembly of a translocon for multipass membrane proteins. | Nature | 2022 | 36261522 | PubTator, text mining | PubMed |
| Network pharmacology study on the potential effect mechanism of Chuanzhi Tongluo Capsule in the treatment of cerebral infarction. | Medicine (Baltimore) | 2022 | 36254030 | PubTator, text mining | PubMed |
| Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cancer risk: an updated meta-analysis of observational studies. | Ther Adv Drug Saf | 2022 | 36249084 | PubTator, text mining | PubMed |
| Genome-wide association study in patients with posterior urethral valves. | Front Pediatr | 2022 | 36238604 | PubTator, text mining | PubMed |
| Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity. | Front Immunol | 2022 | 36238301 | PubTator, text mining | PubMed |
| G-Protein Coupled Receptors in Human Sperm: An In Silico Approach to Identify Potential Modulatory Targets. | Molecules | 2022 | 36235040 | PubTator, text mining | PubMed |
| Angiotensin II type 2 receptor prevents extracellular matrix accumulation in human peritoneal mesothelial cell by ameliorating lipid disorder via LOX-1 suppression. | Ren Fail | 2022 | 36226438 | PubTator, text mining | PubMed |
Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor-Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen-Targeting Small Interfering RNA. | J Am Heart Assoc | 2022 | 36216481 | PubTator, text mining | PubMed |
| Walnut supplementation after fructose-rich diet is associated with a beneficial fatty acid ratio and increased ACE2 expression in the rat heart. | Front Physiol | 2022 | 36213224 | PubTator, text mining | PubMed |
| Key Targets and Molecular Mechanisms of Active Volatile Components of Rabdosia rubescens in Gastric Cancer Cells. | Curr Comput Aided Drug Des | 2022 | 36200190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/186/papers?page=14